Valneva has reported encouraging six-month safety and antibody persistence data from the multi-centre Phase II trial, VLA1553 ...

I have read many books on the changing tide of the public's relationship with vaccines, particularly around childhood ...

Valneva reports positive six-month data for Ixchiq in children, supporting a full dose approach ahead of a Phase 3 trial set ...

Researchers from UConn's College of Agriculture, Health and Natural Resources (CAHNR) and College of Liberal Arts and ...

hWHO Collaborating Centre for New Vaccines Surveillance, Medical Research Council Unit The Gambia at The London School of Hygiene & Tropical Medicine, Fajara, The Gambia iDepartment of Microbiology ...

Despite substantial progress toward its control, Chagas disease continues to be a major public health problem in Latin America and has become a global health concern. The disease affects approximately ...